Orgenesis (STU:45O0) OCF Margin %: -698.26% (As of Dec. 2024)


STU:45O0 Orgenesis Inc STU:45O0
12 GF Score
Price €3.40
View Full Analysis

What is Orgenesis OCF Margin %?

Orgenesis STU:45O0 12 OCF Margin % is -698.26% as of Dec. 2024. GuruFocus rates STU:45O0 with a GF Score™ of 12/100.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Orgenesis's Cash Flow from Operations for the three months ended in Dec. 2024 was €-2.00 Mil. Orgenesis's Revenue for the three months ended in Dec. 2024 was €0.29 Mil. Therefore, Orgenesis's OCF Margin % for the quarter that ended in Dec. 2024 was -698.26%.

As of today, Orgenesis's current OCF Yield % is 0.00%.

The historical rank and industry rank for Orgenesis's OCF Margin % or its related term are showing as below:

STU:45O0' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -1642.34

STU:45O0's OCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -66.52 vs STU:45O0: -1642.34

Orgenesis OCF Margin % Related Terms

Orgenesis OCF Margin % Historical Data

* Premium members only.

The historical data trend for Orgenesis's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orgenesis OCF Margin % Chart

Orgenesis Annual Data
Trend Nov15 Nov16 Nov17 Nov18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,019.94 -75.67 -69.18 -2,799.59 -1,650.61

Orgenesis Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -304.64 -3,143.08 -2,396.51 -1,332.91 -698.26

STU:45O0 vs ENDV, GBLX, OMGAQ: OCF Margin % Comparison

For the Biotechnology subindustry, Orgenesis's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orgenesis OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orgenesis's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Orgenesis's OCF Margin % falls into.


STU:45O0
12GF Score
Orgenesis Inc STU:45O0
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orgenesis OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Orgenesis's OCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-16.308/0.988
=-1,650.61 %

Orgenesis's OCF Margin for the quarter that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-2.004/0.287
=-698.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -698.26% mean?
Orgenesis (STU:45O0) has a OCF Margin % of -698.26% as of Dec. 2024. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Orgenesis and its competitors.
Is Orgenesis' OCF Margin % too high?
Orgenesis' current OCF Margin % is -698.26%. Overall, Orgenesis has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Orgenesis' OCF Margin % compare to ENDV and GBLX?
Orgenesis' OCF Margin % of -698.26% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Orgenesis and its competitors. Orgenesis's current OCF Margin % is -698.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orgenesis stock overvalued right now?
Orgenesis (STU:45O0) has a current OCF Margin % of -698.26%. The current OCF Margin % is -698.26%. Orgenesis' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Orgenesis (STU:45O0), the current OCF Margin % is -698.26% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Orgenesis Business Description

Address 20271 Goldenrod Lane, Germantown, MD, USA, 20876
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies. The company's therapies pipeline includes Immuno-Oncology, Viral Diseases, Metabolic & Autoimmune Diseases, Vascular & Musculoskeletal Diseases, and Kidney Disease.
12GF Score

Get the complete analysis for STU:45O0

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.40
Price